Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 2
1974 1
1975 6
1976 3
1977 3
1978 8
1979 4
1980 10
1981 3
1982 8
1983 12
1984 10
1985 8
1986 5
1987 10
1988 9
1989 13
1990 12
1991 4
1992 14
1993 14
1994 18
1995 8
1996 7
1997 10
1998 14
1999 24
2000 21
2001 24
2002 17
2003 16
2004 18
2005 28
2006 33
2007 19
2008 25
2009 14
2010 17
2011 16
2012 16
2013 14
2014 13
2015 20
2016 8
2017 14
2018 12
2019 9
2020 13
2021 16
2022 8
2023 6
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

601 results

Results by year

Filters applied: . Clear all
Page 1
Clinical impact of using [18F]AlF-NOTA-octreotide PET/CT instead of [68Ga]Ga-DOTA-SSA PET/CT: Secondary endpoint analysis of a multicenter, prospective trial.
Leupe H, Pauwels E, Vandamme T, Van den Broeck B, Lybaert W, Dekervel J, Van Herpe F, Jaekers J, Cleeren F, Hofland J, Brouwers A, Koole M, Bormans G, Van Cutsem E, Geboes K, Laenen A, Verslype C, Stroobants S, Deroose CM. Leupe H, et al. Among authors: geboes k. J Neuroendocrinol. 2024 Jun 4:e13420. doi: 10.1111/jne.13420. Online ahead of print. J Neuroendocrinol. 2024. PMID: 38837825
Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1): a single-arm, multicentre phase 1b/2 study.
Van Laethem JL, Borbath I, Prenen H, Geboes KP, Lambert A, Mitry E, Cassier PA, Blanc JF, Pilla L, Batlle JF, Garrote MR, Pazo-Cid RA, Gallego I, Smith KE, Ellmark P, Pico de Coaña Y, Ambarkhane SV, Macarulla T. Van Laethem JL, et al. Among authors: geboes kp. Lancet Oncol. 2024 May 31:S1470-2045(24)00263-8. doi: 10.1016/S1470-2045(24)00263-8. Online ahead of print. Lancet Oncol. 2024. PMID: 38834087
Sexual satisfaction and its predictors in patients with advanced cancer and their family caregivers in six European countries: Baseline data from the DIAdIC study.
Matthys O, Dierickx S, Van Goethem V, Deliens L, Lapeire L, De Pauw A, Hudson P, Vulsteke C, Geboes K, De Waele S, Spoormans I, Di Leo S, Guberti M, Schmidt US, Scott D, Harding R, Witkamp E, Connolly M; DIAdIC team; De Vleminck A, Cohen J. Matthys O, et al. Among authors: geboes k. Psychooncology. 2024 Jun;33(6):e6347. doi: 10.1002/pon.6347. Psychooncology. 2024. PMID: 38804579
Safety and feasibility of chemotherapy followed by liver transplantation for patients with definitely unresectable colorectal liver metastases: insights from the TransMet randomised clinical trial.
Adam R, Badrudin D, Chiche L, Bucur P, Scatton O, Granger V, Ducreux M, Cillo U, Cauchy F, Lesurtel M, Mabrut JY, Verslype C, Coubeau L, Hardwigsen J, Boleslawski E, Muscari F, Jeddou H, Pezet D, Heyd B, Lucidi V, Geboes K, Lerut J, Majno P, Grimaldi L, Boukhedouni N, Piedvache C, Gelli M, Levi F, Lewin M. Adam R, et al. Among authors: geboes k. EClinicalMedicine. 2024 Apr 27;72:102608. doi: 10.1016/j.eclinm.2024.102608. eCollection 2024 Jun. EClinicalMedicine. 2024. PMID: 38721015 Free PMC article.
Preoperative treatment with mFOLFIRINOX or Gemcitabine/Nab-paclitaxel +/- isotoxic high-dose stereotactic body Radiation Therapy (iHD-SBRT) for borderline resectable pancreatic adenocarcinoma (the STEREOPAC trial): study protocol for a randomised comparative multicenter phase II trial.
Bouchart C, Navez J, Borbath I, Geboes K, Vandamme T, Closset J, Moretti L, Demetter P, Paesmans M, Van Laethem JL. Bouchart C, et al. Among authors: geboes k. BMC Cancer. 2023 Sep 21;23(1):891. doi: 10.1186/s12885-023-11327-x. BMC Cancer. 2023. PMID: 37735634 Free PMC article.
Prospective comparison of [18F]AlF-NOTA-octreotide PET/MRI to [68Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patients.
Boeckxstaens L, Pauwels E, Vandecaveye V, Deckers W, Cleeren F, Dekervel J, Vandamme T, Serdons K, Koole M, Bormans G, Laenen A, Clement PM, Geboes K, Van Cutsem E, Nackaerts K, Stroobants S, Verslype C, Van Laere K, Deroose CM. Boeckxstaens L, et al. Among authors: geboes k. EJNMMI Res. 2023 Jun 1;13(1):53. doi: 10.1186/s13550-023-01003-3. EJNMMI Res. 2023. PMID: 37261615 Free PMC article.
Mucin-microbiome signatures shape the tumor microenvironment in gastric cancer.
Oosterlinck B, Ceuleers H, Arras W, De Man JG, Geboes K, De Schepper H, Peeters M, Lebeer S, Skieceviciene J, Hold GL, Kupcinskas J, Link A, De Winter BY, Smet A. Oosterlinck B, et al. Among authors: geboes k. Microbiome. 2023 Apr 21;11(1):86. doi: 10.1186/s40168-023-01534-w. Microbiome. 2023. PMID: 37085819 Free PMC article.
The pitfalls of 68Ga-DOTATATE Imaging. A case report.
D'Cruz VA, Libbrecht S, Hoorens A, De Man K, van Ramshorst GH, Geboes KP. D'Cruz VA, et al. Among authors: geboes kp. Acta Gastroenterol Belg. 2023 Jan-Mar;86(1):92-94. doi: 10.51821/86.1.9725. Acta Gastroenterol Belg. 2023. PMID: 36842179 Free article. No abstract available.
601 results